Crt-miR166a, a Citrus-Derived MicroRNA, Modulates the Gut Microbiota-Metabolites under High-Fat Diet

Minmin Zhan1, Chenxi Zhao1, Bin Chen2

  • 1Department of Food Science and Nutrition, College of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou 310058, China.

Insights

Citrus microRNA crt-miR166a improves gut health by balancing beneficial bacteria and metabolites in mice fed a high-fat diet. This plant-derived microRNA (miRNA) alleviates diet-induced gut dysbiosis.

Area of Science:

  • Microbiology
  • Metabolomics
  • Molecular Biology

Background:

  • High-fat diets (HFD) disrupt gut microbiota and metabolite balance.
  • Plant microRNAs (miRNAs) role in modulating gut microbiota metabolites is unclear.
  • Gut microbiota metabolites like short-chain fatty acids, bile acids, and indoles are crucial for host health.

Purpose of the Study:

  • To investigate the effect of citrus-derived crt-miR166a on HFD-induced gut microbiota-metabolite dysbiosis.
  • To determine if crt-miR166a can restore metabolic balance in the gut.

Main Methods:

  • Mice were fed a high-fat diet (HFD).
  • crt-miR166a was administered to HFD-fed mice.
  • Gut microbiota composition and key metabolites (SCFAs, bile acids, indole derivatives) were analyzed.

Main Results:

  • crt-miR166a increased beneficial bacteria (e.g., Bacteroides, Acetatifactor).
  • crt-miR166a elevated beneficial short-chain fatty acids (acetic, butyric, valeric acids).
  • crt-miR166a modulated bile acid profiles and increased tryptophan-derived indole derivatives.

Conclusions:

  • Citrus microRNA crt-miR166a effectively alleviates HFD-induced gut microbiota-metabolite dysbiosis.
  • crt-miR166a demonstrates potential as a dietary modulator for improving metabolic health.
  • Plant-derived miRNAs offer novel therapeutic avenues for diet-related gut disorders.

Related Concept Videos

Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Functions of the Gut Microbiota01:18

Functions of the Gut Microbiota

The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
Microbiota of the Large Intestine01:27

Microbiota of the Large Intestine

The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...